Table 3. Baseline and follow-up concentrations of hs-cTnI in (pre)frail older subjects in the control group and those participating in a 24-week resistance-type exercise training program.

Variable	(pre)Frail older subjects 24-w intervention (n = 25)	(pre)Frail older subjects no intervention (n = 27)
Baseline hs-cTnI (ng/L), median (IQR)	4.4 (3.3–6.2)	6.7 (4.7–7.7)
12-week hs-cTnI (ng/L), median (IQR)	4.6 (3.5–6.4)	6.7 (4.4–8.4)
24-week hs-cTnI (ng/L), median (IQR)	4.3 (3.6–8.4)	6.0 (3.4–7.6)